Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania
Background The COVID-19 pandemic affected healthcare delivery globally, impacting care access and delivery of essential services. Objectives We investigated the pandemic’s impact on care for patients with type 2 diabetes and factors associated with care disruption in Kenya and Tanzania. Methods A cr...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Global Health Action |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/16549716.2024.2345970 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832096650239148032 |
|---|---|
| author | Richard E. Sanya Caroline H. Karugu Peter Binyaruka Shukri F. Mohamed Lyagamula Kisia Peter Kibe Irene Mashasi Grace Mhalu Christopher Bunn Manuela Deidda Frances S. Mair Eleanor Grieve Cindy M. Gray Sally Mtenga Gershim Asiki |
| author_facet | Richard E. Sanya Caroline H. Karugu Peter Binyaruka Shukri F. Mohamed Lyagamula Kisia Peter Kibe Irene Mashasi Grace Mhalu Christopher Bunn Manuela Deidda Frances S. Mair Eleanor Grieve Cindy M. Gray Sally Mtenga Gershim Asiki |
| author_sort | Richard E. Sanya |
| collection | DOAJ |
| description | Background The COVID-19 pandemic affected healthcare delivery globally, impacting care access and delivery of essential services. Objectives We investigated the pandemic’s impact on care for patients with type 2 diabetes and factors associated with care disruption in Kenya and Tanzania. Methods A cross-sectional study was conducted among adults diagnosed with diabetes pre-COVID-19. Data were collected in February–April 2022 reflecting experiences at two time-points, three months before and the three months most affected by the COVID-19 pandemic. A questionnaire captured data on blood glucose testing, changes in medication prescription and access, and healthcare provider access. Results We recruited 1000 participants (500/country). Diabetes care was disrupted in both countries, with 34.8% and 32.8% of the participants reporting change in place and frequency of testing in Kenya, respectively. In Tanzania, 12.4% and 17.8% reported changes in location and frequency of glucose testing, respectively. The number of health facility visits declined, 14.4% (p < 0.001) in Kenya and 5.6% (p = 0.001) in Tanzania. In Kenya, there was a higher likelihood of severe care disruption among insured patients (adjusted odds ratio [aOR] 1.56, 95% confidence interval [CI][1.05–2.34]; p = 0.029) and a lower likelihood among patients residing in rural areas (aOR, 0.35[95%CI, 0.22–0.58]; p < 0.001). Tanzania had a lower likelihood of severe disruption among insured patients (aOR, 0.51[95%CI, 0.33–0.79]; p = 0.003) but higher likelihood among patients with low economic status (aOR, 1.81[95%CI, 1.14–2.88]; p = 0.011). Conclusions COVID-19 disrupted diabetes care more in Kenya than Tanzania. Health systems and emergency preparedness should be strengthened to ensure continuity of service provision for patients with diabetes. |
| format | Article |
| id | doaj-art-2393a42c862440b8a958959c095db6aa |
| institution | Kabale University |
| issn | 1654-9880 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Global Health Action |
| spelling | doaj-art-2393a42c862440b8a958959c095db6aa2025-02-05T12:46:13ZengTaylor & Francis GroupGlobal Health Action1654-98802024-12-0117110.1080/16549716.2024.23459702345970Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and TanzaniaRichard E. Sanya0Caroline H. Karugu1Peter Binyaruka2Shukri F. Mohamed3Lyagamula Kisia4Peter Kibe5Irene Mashasi6Grace Mhalu7Christopher Bunn8Manuela Deidda9Frances S. Mair10Eleanor Grieve11Cindy M. Gray12Sally Mtenga13Gershim Asiki14African Population and Health Research CenterAfrican Population and Health Research CenterIfakara Health InstituteAfrican Population and Health Research CenterAfrican Population and Health Research CenterAfrican Population and Health Research CenterIfakara Health InstituteIfakara Health InstituteUniversity of GlasgowUniversity of GlasgowUniversity of GlasgowUniversity of GlasgowUniversity of GlasgowIfakara Health InstituteAfrican Population and Health Research CenterBackground The COVID-19 pandemic affected healthcare delivery globally, impacting care access and delivery of essential services. Objectives We investigated the pandemic’s impact on care for patients with type 2 diabetes and factors associated with care disruption in Kenya and Tanzania. Methods A cross-sectional study was conducted among adults diagnosed with diabetes pre-COVID-19. Data were collected in February–April 2022 reflecting experiences at two time-points, three months before and the three months most affected by the COVID-19 pandemic. A questionnaire captured data on blood glucose testing, changes in medication prescription and access, and healthcare provider access. Results We recruited 1000 participants (500/country). Diabetes care was disrupted in both countries, with 34.8% and 32.8% of the participants reporting change in place and frequency of testing in Kenya, respectively. In Tanzania, 12.4% and 17.8% reported changes in location and frequency of glucose testing, respectively. The number of health facility visits declined, 14.4% (p < 0.001) in Kenya and 5.6% (p = 0.001) in Tanzania. In Kenya, there was a higher likelihood of severe care disruption among insured patients (adjusted odds ratio [aOR] 1.56, 95% confidence interval [CI][1.05–2.34]; p = 0.029) and a lower likelihood among patients residing in rural areas (aOR, 0.35[95%CI, 0.22–0.58]; p < 0.001). Tanzania had a lower likelihood of severe disruption among insured patients (aOR, 0.51[95%CI, 0.33–0.79]; p = 0.003) but higher likelihood among patients with low economic status (aOR, 1.81[95%CI, 1.14–2.88]; p = 0.011). Conclusions COVID-19 disrupted diabetes care more in Kenya than Tanzania. Health systems and emergency preparedness should be strengthened to ensure continuity of service provision for patients with diabetes.http://dx.doi.org/10.1080/16549716.2024.2345970diabetescovid-19chronic disease carehealth systemsafrica |
| spellingShingle | Richard E. Sanya Caroline H. Karugu Peter Binyaruka Shukri F. Mohamed Lyagamula Kisia Peter Kibe Irene Mashasi Grace Mhalu Christopher Bunn Manuela Deidda Frances S. Mair Eleanor Grieve Cindy M. Gray Sally Mtenga Gershim Asiki Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania Global Health Action diabetes covid-19 chronic disease care health systems africa |
| title | Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania |
| title_full | Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania |
| title_fullStr | Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania |
| title_full_unstemmed | Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania |
| title_short | Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania |
| title_sort | impact of the covid 19 pandemic on type 2 diabetes care and factors associated with care disruption in kenya and tanzania |
| topic | diabetes covid-19 chronic disease care health systems africa |
| url | http://dx.doi.org/10.1080/16549716.2024.2345970 |
| work_keys_str_mv | AT richardesanya impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT carolinehkarugu impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT peterbinyaruka impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT shukrifmohamed impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT lyagamulakisia impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT peterkibe impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT irenemashasi impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT gracemhalu impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT christopherbunn impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT manueladeidda impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT francessmair impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT eleanorgrieve impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT cindymgray impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT sallymtenga impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania AT gershimasiki impactofthecovid19pandemicontype2diabetescareandfactorsassociatedwithcaredisruptioninkenyaandtanzania |